Transgenicaily produced human antithrombin: Structural and functional comparison to human plasma-derived antithrombin

Blood

Volumn 91, Issue 12, 1998, Pages 4561-4571

  Edmunds, Tim ^a   Van Patten, Scott M ^a   Pollock, Julie ^a   Hanson, Eric ^a   Bernasconi, Richard ^a   Higgins, Elizabeth ^a   Manavalan, Partha ^a   Ziomek, Carol ^a   Meade, Harry ^a   McPherson, John M ^a   Cole, Edward S ^a  

^a GENZYME CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN; HEPARIN; MANNOSE; N ACETYLNEURAMINIC ACID; N GLYCOLOYLNEURAMINIC ACID; RECOMBINANT ANTITHROMBIN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; ANTITHROMBIN III; MILK PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; FEMALE; GOAT; MALE; MILK; NONHUMAN; PLASMA; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN GLYCOSYLATION; PROTEIN SYNTHESIS; SIALYLATION; TRANSGENIC ANIMAL; ANIMAL; GENETICS; HUMAN; ISOLATION AND PURIFICATION; PROTEIN ENGINEERING;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANTITHROMBIN III; FEMALE; GOATS; HUMANS; MILK PROTEINS; PROTEIN ENGINEERING; RECOMBINANT PROTEINS;

EID: 0031596139     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.12.4561.412k21_4561_4571     Document Type: Article

References (60)

1. Travis J, Salvesen GS: Human plasma proteinase inhibitors. Annu Rev Biochem 52:655, 1983
2. Menache D: Antithrombin III: Introduction. Semin Hernatol 28:1, 1991
3. Menache D, Grossman B, Jackson C: Antithrombin III: Physiology, deficiency, and replacement therapy. Transfusion 32:580, 1992
4. Lahiri B, Bagdasarian A, Mitchell B, Talamo RC, Colman RW, Rosenberg RD: Antithrombin-Heparin Cofactor: An inhibitor of plasma kallikrein. Arch Biochem Biophys 175:737, 1976
5. Rosenberg RD, Bauer KA, Marcum JA: Antithrombin III, The heparin antithrombin system. Rev Hematol 2:351, 1986
6. Murano G, Williams L, Andersson M: Some properties of antithrombin III and its concentration in human plasma. Thromb Res 18:259, 1980
7. Franzen LE, Svensson S, Larm O: Structural studies on the carbohydrate portion of human antithrombin III. J Biol Chem 255:5090, 1980
8. 1 antitrypsin and antithrombin-III, in Collen DW, Wiman B, Verstraete M (eds): The Physiological Inhibitions of Blood Coagulation and Fibrinolysis. Amsterdam, The Netherlands, Elsevier/ North-Holland Biomedical Press, 1979, p 43
9. Pike R, Potempa J, Skinner R, Fitton H, McGraw W, Travis J, Owen M, Jin L, Carrell R: Heparin-dependent modification of the reactive center arginine of antithrombin and consequent increase in heparin binding affinity. J Biol Chem 272:19652, 1997
10. Ersdal-Badju E, Lu A, Zuo Y, Picard V, Bock S: Identification of the antithrombin III heparin binding site. J Biol Chem 272:19393, 1997
11. Rosenberg RD: Role of heparin and heparinlike molecules in thrombosis and atherosclerosis. Fed Proc 44:404, 1985
12. Bjork I, Danielsson A: Antithrombin and related inhibitors of coagulation proteinases. in Barrett AJ, Salvesen GS (eds): Proteinase Inhibitors, vol 17. Amsterdam, The Netherlands, Elsevier Science Publishers (Biomedical Division), 1986, p 489
13. Olson ST, Bjork I, Sheffer R, Craig PA, Shore JD, Choay J: Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrombin-proteinase reactions. Resolution of the antithrombin conformational change contribution to heparin rate enhancement. J Biol Chem 267:12528, 1992
14. Choay J, Lormeau JC, Petitou M, Sinay P, Farced J: Structural studies on a biologically active hexasaccharide obtained from heparin. Ann NY Acad Sci 370:644, 1981
15. Choay J, Petitou M, Lormeau J-C, Sinay P, Casu B, Gatti G: Structure activity relationship in heparin: A synthetic pentasaccharide sequence with high affinity for antithrombin III and eliciting high anti factor Xa activity. Biochem Biophys Res Commun 116:492, 1983
16. Olson ST, Bjork I: Predominant contribution of surface approximation to the mechanism of heparin acceleration of the antithrombin-thrombin reaction. Elucidation from salt concentration effects. J Biol Chem 266:6353, 1991
17. Bauer KA, Rosenberg RD: Role of antithrombin III as a regulator of in vivo coagulation. Semin Hematol 28:10, 1991
18. Carrell R, Skinner R, Jin L, Abrahams J: Structural mobility of antithrombin and its modulation by heparin. Thromb Haemost 78:516, 1997
19. Hashimoto K, Yamagishi M, Sasaki T, Nakano M, Kurosawa H: Heparin and Antithrombin III levels during Cardiopulmonary bypass: Correlation with subclinical plasma coagulation. Ann Thorac Surg 58:799, 1994
20. Cloyd GM, D'Ambra MN, Akins CW: Diminished anticoagulant response to heparin in patients undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 94:535, 1987
21. Rosenberg RD: Biochemistry of heparin antithrombin interactions, and the physiologic role of this natural anticoagulant mechanism. Am J Med 87:2S, 1989 (suppl)
22. Mertens G, Cassiman J-J, Van den Berghe H, Vermylen J, David G: Cell surface heparan sulfate proteoglycans from human vascular endothelial cells. J Biol Chem 267:20435, 1992
23. Akai T, Kaji T, Hayakawa Y, Hayashi T, Sakuragawa N: Antithrombin modulates the effect of thrombin in the metabolism of glycosaminoglycans in cultured endothelial cells. Thrombosis Res 62:707, 1991
24. de-Agostini AI, Watkins SC, Slayter HS, Youssoufian H, Rosenberg RD: Localization of anticoagulantly active heparan sulfate proteoglycans in vascular endothelium: Antithrombin binding on cultured endothelial cells and perfused rat aorta. J Cell Biol 111:1293, 1990
25. Ebert KM, Selgrath JP, DiTullio P, Denman J, Smith TE, Memon MA, Schindler JE, Monastersky GM, Vitale JA, Gordon C: Transgenic production of a variant of human tissue-type plasminogen activator in goat milk: Generation of transgenic goats and analysis of expression. Bio/Technology 9:835, 1991
26. Denman J, Hayes M, O'Day C, Edmunds T, Bartlett C, Hirani S, Ebert KM, Gordon K, McPherson JM: Transgenic expression of a variant of human tissue-type plasminogen activator in goat milk: Purification and characterization of the recombinant enzyme. Bio/Technology 9:839, 1991
27. Ebert KM, DiTullio P, Barry CA, Schindler JE, Ayres SL, Smith TE, Pellerin LJ, Meade HM, Denman J, Roberts B: Induction of human tissue plasminogen activator in the mammary gland of transgenic goats. Bio/Technology 12:699, 1994
28. Varki A: Biological roles of oligosaccharides: All of the theories are correct. Glycobiology 3:97, 1993
29. Roberts B, DiTullio P, Vitale J, Hehir K, Gordon K: Cloning of the goat-casein encoding gene and expression in transgenic mice. Gene 121:255, 1992
30. DiTullio P, Cheng SH, Marshal J, Gregory RJ, Ebert KM, Meade HM, Smith AE: Production of cystic fibrosis transmembrane regulator in the milk of transgenic mice. Bio/Technology 10:74, 1992
31. Broker M, Ragg H, Karges HE: Expression of human antithrombin III in Saccharomyces cerevisiae and Schizosaccharomyces pombe. Biochim Biophys Acta 908:203, 1987
32. Gould SJ, Subramani S, Scheffler IE: Use of the DNA polymerase chain reaction for homology probing: Isolation of partial cDNA or genomic clones encoding the iron-sulfur protein succinate dehydrogenase from several species. Proc Natl Acad Sci USA 86:1934, 1989
33. Abildgaard U, Lie M, Odegard OR: Antithrombin (heparin cofactor) assay with "new" chromogenic substrates (S-2238 and Chromozym THJ. Thromb Res 11:549, 1977
34. Abildgaard U: Methodological considerations on antithrombin determination. Acta Chir Scand Suppl 509:97, 1982
35. Cole ES, Nichols EH, Lauziere K, Edmunds T, McPherson JM: Characterization of the microheterogeneity of recombinant primate prolactin: Implications for posttranslational modifications of the hormone in vivo. Endocrinology 129:2639, 1991
36. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680, 1970
37. Morrissey JH: Silver stain for proteins in polyacrylamide gels: A modified procedure with enhanced uniform sensitivity. Anal Biochem 117:307, 1981
38. Burnette WN: "Western Blotting." Electrophoretic transfer of proteins from SDS-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal Biochem 170:195, 1981
39. Hardy MR, Townsend RR, Lee YC: Monosaccharide analysis of glycoconjugates by anion exchange chromatography with pulsed amperometric detection. Anal Biochem 170:54, 1988
40. Powell LD, Hart GW: Quantitation of picomole levels of N-acetyl- and N-glycolylneuraminic acids by a HPLC-adaptation of the thiobarbituric acid assay. Anal Biochem 157:179, 1986
41. Fan B, Crews BC, Turko IV, Choay J, Zettlmeissl G, Gettins P: Heterogeneity of recombinant human antithrombin III expressed in baby hamster kidney cells. Effect of glycosylation differences on heparin binding and structure. J Biol Chem 268:17588, 1993
42. Knobloch J, Shaklee P: Absolute molecular weight distribution of low-molecular weight heparins by size-exclusion chromatography with multiangle laser light scattering detection. Anal Biochem 245:231, 1997
43. Carrell RW, Stein PE, Fermi G, Wardell MR: Biological implications of a 3A structure of dimeric antithrombin. Structure 2:257, 1994
44. Schreuder HA, de-Boer B, Dijkema R, Mulders J, Theunissen HJ, Grootenhuis PD, Hol WG: The intact and cleaved human antithrombin III complex as a model for serpin-proteinase interactions. Nat Struct Biol 1:48, 1994
45. Nordenman B, Nystrom C, Bjork I: The size and shape of human and bovine antithrombin III. Eur J Biochem 78:195, 1977
46. Frebelius S, Isaksson S, Swedenborg J: Thrombin inhibition by antithrombin III on the subendothelium is explained by the isoform AT beta. Arterioscler Thromb Vase Biol 16:1292, 1996
47. Peterson CB, Blackburn MN: Isolation and characterization of an antithrombin III variant with reduced carbohydrate content and enhanced heparin binding. J Biol Chem 260:610, 1985
48. Zettlmeissl G, Conradt HS, Nimtz M, Haigwood N, Paques EP: Influence of glycosylation on the functional properties of human therapeutic plasma proteins. GBF Monogr Ser 15:259, 1991
49. Olson S, Frances-Chmura A, Swanson R, Bjork I, Zettlmeissl G: Effect of individual carbohydrate chains of recombinant antithrombin on heparin affinity and on the generation of glycoforrns differing in heparin affinity. Arch Biochem Biophys 341:212, 1997
50. Garone L, Edmunds T, Hanson E, Bernasconi R, Huntington JA, Meagher JL, Fan B, Gettins PGW: Amithrombin-heparin affinity reduced by fucosylation of carbohydrate at asparagine 155. Biochemistry 35:8881, 1996
51. Hatton MWC, Moar SL, Richardson M: On the interaction of rabbit antithrombin III with the luminal surface of the normal and de-endothelialized rabbit thoracic aorta in vitro. Blood 67:878, 1986
52. 125I-antithrombin III binds to proteoheparan sulphate at the subendothelium of the rabbit aorta in vitro. Blood Vessels 25:12, 1988
53. Pizzo SV: Serpin receptor 1: A hepatic receptor that mediates the clearance of antithrombin III-proteinase complexes. Am J Med 87:10S, 1989 (suppl)
54. Weksler BB, Ley CW, Jaffe EA: Stimulation of endothelial cell prostacyclin production by thrombin, trypsin and theionophore A23187. J Clin Invest 62:923, 1978
55. Levin EG, Loskutoff PJ: Cultured bovine endothelial cells produce both urokinase and tissue-type plasminogen activators. J Cell Biol 94:631, 1982
56. Gelehter TJ, Sznycer-Laszuk R: Thrombin induction of plasminogen activator-inhibitor in cultured human endothelial cells. J Clin Invest 77:165, 1986
57. Kaji T, Itoh F, Hayakawa Y, Oguma Y, Sakurgawa N: Interaction of thrombin with heparin cofactor II and antithrombin III on prostacyclin production by cultured endothelial cells. Thromb Res 56:99, 1989
58. Toothill VJ, Van Mourik JS, Niewenhuis hK, Metzelaar MJ, Pearson JD: Characterization of the enhanced adhesion of neutrophil leukocytes to thrombin-stimulated endothelial cells. J Immunol 145: 283, 1990
59. Moser R, Groscurth P, Fehr J: Promotion of transendothelial neutrophil passage by human thrombin. J Cell Science 96:737, 1990
60. Fuse S, Tomita H, Yoshida M, Hori T, Igarashi C, Fujita S: High dose of intravenous antithrombin III without heparin in the treatment of disseminated intravascular coagulation and organ failure in four children. Am J Hematol 53:18, 1996